The role of health economic analyses in vaccine decision making
Open Access
- 1 December 2013
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 31 (51), 6046-6049
- https://doi.org/10.1016/j.vaccine.2013.08.008
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Cost-Effectiveness of Pneumococcal Conjugate VaccineThe Pediatric Infectious Disease Journal, 2006
- Population-Based Analysis of Meningococcal Disease Mortality in the United StatesThe Pediatric Infectious Disease Journal, 2006
- Edward Jenner and the History of Smallpox and VaccinationBaylor University Medical Center Proceedings, 2005
- Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysisHealth Economics, 2004
- Impact of the pneumococcal conjugate vaccine on otitis mediaThe Pediatric Infectious Disease Journal, 2003
- Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998Opportunities for Prevention in the Conjugate Vaccine EraPublished by American Medical Association (AMA) ,2001
- Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young ChildrenJAMA, 2000